Role of the IGF-1 Axis in Overcoming Resistance in Breast Cancer
Over the last two decades, many studies have demonstrated that the insulin-like growth factor-1 (IGF-1) is involved in a number of patho-physiological processes, as well as in the development of different types of solid tumors, including breast cancer (BC). Preclinical and clinical data showed that...
Main Authors: | Anna Ianza, Marianna Sirico, Ottavia Bernocchi, Daniele Generali |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2021.641449/full |
Similar Items
-
Therapeutic Targeting of the IGF Axis
by: Eliot Osher, et al.
Published: (2019-08-01) -
Unraveling the Resistance of IGF-Pathway Inhibition in Ewing Sarcoma
by: Stefanie de Groot, et al.
Published: (2020-11-01) -
IGF-1/IGF-1R/FAK/YAP Transduction Signaling Prompts Growth Effects in Triple-Negative Breast Cancer (TNBC) Cells
by: Damiano Cosimo Rigiracciolo, et al.
Published: (2020-04-01) -
Elevated serum concentrations of IGF-1 and IGF-1R in patients with thyroid cancers
by: Hanna Lawnicka, et al.
Published: (2020-03-01) -
The IGF/Insulin-IGFBP Axis in Corneal Development, Wound Healing, and Disease
by: Whitney L. Stuard, et al.
Published: (2020-03-01)